Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03680703 · ClinicalTrials.gov registry record · NA

Bariatric Scalable Internet Treatments

A NA study of Weight Loss and Bariatric Surgery, sponsored by Yale University.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT03680703 is a NA study of Weight Loss and Bariatric Surgery that has completed, run by Yale University. The registered enrollment target is 33 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03680703, a NA study of Weight Loss and Bariatric Surgery, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to conduct a randomized clinical trial examining the feasibility and effectiveness of two guided self-help behavioral weight loss (gshBWL) treatments delivered via the internet for individuals struggling with weight loss one year following bariatric surgery. The two treatments will consist of 1) gshBWL delivered through the internet only (gshBWL-I) and 2) gshBWL delivered via the internet with additional complementary phone sessions (gshBWL-IP).

Interventions

  • BEHAVIORAL Guided Self-Help Behavioral Weight Loss

Study Locations (1)

Connecticut

  • Yale Department of Psychiatry - New Haven

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2018-07-20
Est. Completion 2019-12-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03680703

The ClinicalTrials.gov registry entry for NCT03680703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (98% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Weight Loss appearing as the primary indexed condition, and to 1 intervention - of which Guided Self-Help Behavioral Weight Loss is the first listed.

NCT03680703 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT03680703 about?

NCT03680703 is a clinical study titled "Bariatric Scalable Internet Treatments". The purpose of the study is to conduct a randomized clinical trial examining the feasibility and effectiveness of two guided self-help behavioral weight loss (gshBWL) treatments delivered via the internet for individuals struggling with weight loss one year following bariatric surgery. The two treat...

What is the current status of trial NCT03680703?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2018-07-20. Estimated completion is 2019-12-31.

What conditions does trial NCT03680703 study?

This clinical trial studies the following conditions: Weight Loss, Bariatric Surgery.

What interventions are being tested in trial NCT03680703?

The interventions under investigation include: Guided Self-Help Behavioral Weight Loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT03680703?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03680703 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.